Biotech Startups

Nanordica Medical develops the Nanordica Advanced Antibacterial Wound Dressing, a sterile single-use dressing made of natural silk nanofibers with antibacterial nanoparticles (Premotiv technology) that prevents infection and promotes healing of chronic and infected wounds such as diabetic foot ulcers. The Estonian medtech company, a spin-off of the National Institute of Chemical Physics and Biophysics, serves wound-care and clinical settings.

1 investor

NanoScoping is a Brazilian biotechnology company that uses its nTechnology nanotechnology platform to develop biocompatible, biodegradable active ingredients with properties like prolonged release and better penetration. Its inputs serve the cosmetics, veterinary dermatology, nutritional supplement, and agricultural sectors.

1 investor

NanoSuit株式会社 develops the Japan-originated NanoSuit® method, a technology that enables electron microscope observation of living organisms, fixed specimens, cells, and biological particles such as viruses and exosomes in a wet or living state with minimal changes to fine structures. Spun out from Hamamatsu University School of Medicine research, it targets applications in life sciences, healthcare, cosmetics, and food.

1 investor

NanoSyrinx develops a technology platform for biopharmaceutical applications, with expertise in drug discovery, cell therapy, and biologic development. The company serves biotech and pharmaceutical customers working on therapeutics and medical treatments.

1 investor

NanoTess is a social enterprise developing catalytic materials to address wound care and skin health challenges, with a focus on making healthcare technologies accessible and affordable for patients and communities globally.

1 investor

Nanotherm Therapeutics develops a thermal ablation method for treating solid tumors, using nanoparticle activation to deliver targeted, contact-less heating in an image-guided, 2-step workflow. The approach is aimed at oncology treatment, delivering nanoparticles via a standard 19G needle and enabling same-day diagnosis and treatment.

1 investor

NanoVation Therapeutics develops lipid nanoparticle (LNP) and mRNA delivery technologies for gene therapies, supporting drug development partners across mRNA synthesis, LNP formulation, and preclinical delivery optimization. It works with pharmaceutical and biotech partners on end-to-end gene therapy delivery.

1 investor

Nanovis develops and manufactures nanoscale surface technologies designed to improve the integration of orthopedic, spinal, and dental implants. It supplies these implant surface technologies to medical device makers and OEM partners in the medtech industry.

1 investor

Clinical-stage biopharmaceutical company developing oligonucleotide therapeutics using an immune cell-targeted delivery platform.

1 investor

Napigen is a biotechnology company developing genome editing technology targeting the mitochondrial and chloroplast genomes.

1 investor

Narrativa provides generative AI automation for medical writing, focused on drafting patient safety narratives and clinical trial regulatory documentation for pharmaceutical companies. Its platform automates data analysis and narrative authoring to speed up drug trial documentation and regulatory approvals.

1 investor

Natac is a company focused on natural products research that organizes the Premios Nacionales de Investigación Natac, national awards recognizing scientific work on bioactive compounds and natural product extraction.

1 investor

The National Cancer Institute is the federal government's principal agency for cancer research and training, supporting a broad research portfolio to advance progress against cancer.

1 investor

Naturacare is a full-service CDMO (contract development and manufacturing organization) that designs, develops, and produces natural health products and dietary supplements for both humans and animals. It offers dosage form development, custom formulations, ingredient sourcing, and eco-designed packaging for brands across various distribution channels, operating five production sites in Europe.

1 investor

Natural Trace develops a food-grade, DNA-based tagging system (NaturalTag) with a detection kit (NaturalDetect) and a digital platform (NaturalCloud) to authenticate food products and trace them through the supply chain. It serves food producers and ingredient owners seeking in-product traceability, provenance verification, and regulatory compliance.

1 investor

NatureMetrics provides a platform that unifies biodiversity data from multiple sources including eDNA, geospatial, and predictive analytics to help organizations monitor nature-related risks and report on environmental impact. The platform serves sustainability teams, ESG leaders, and risk officers who need to analyze biodiversity metrics and comply with environmental reporting standards like TNFD and CSRD.

1 investor

ApiSave develops diagnostic and treatment solutions for honeybee health, targeting beekeepers and agricultural organizations concerned with protecting bee populations and food system sustainability.

1 investor

NAV Vaccine develops preventive and therapeutic drugs using immune system technology. The company focuses on cancer treatments, immunotherapy combination therapies, viral prevention vaccines, and tissue regeneration therapeutics.

1 investor

1 investor

Navigene develops AI-enabled diagnostic tests using proprietary processes and lab automation, focusing on accurate, affordable, next-generation diagnostics. It serves patients by offering precise testing along with disease management counseling.

1 investor

1 investor

NB Health Laboratory develops antibody therapeutics for drug discovery and development to address unmet medical needs in healthcare.

1 investor

NC Biomatrix develops biologic therapies targeting musculoskeletal degeneration, with a lead product (VitaDisc) addressing intervertebral disc degeneration and chronic lower back pain, and ongoing research into osteoarthritis treatments for synovial joints.

1 investor

Ncardia develops induced pluripotent stem cell (iPSC) technologies and services for drug discovery, safety testing, and regenerative medicine applications. The company serves pharmaceutical and biotech organizations seeking advanced cellular models to accelerate therapeutic development and validate drug candidates.

1 investor